<header id=058644>
Published Date: 2015-04-08 16:24:13 EDT
Subject: PRO/EDR> Gonococcal disease - Australia (03): (VI) screening, NAAT, comment
Archive Number: 20150408.3284108
</header>
<body id=058644>
GONOCOCCAL DISEASE - AUSTRALIA (03): (VICTORIA) SCREENING, NUCLEIC ACID AMPLIFICATION TEST (NAAT), COMMENT
**********************************************************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: Tue 7 Apr 2015
From: Andre Burnens <aburnens@bluewin.ch> [edited]


Re: ProMED-mail Gonococcal disease - Australia: (VI) screening, NAAT 20150401.3270179
----------------------------------------------------------------------
Very interesting -- thank you for pointing out the article to our attention. Useful reminder of the fact that:
- the specificity of certain _Neisseria gonorrhoeae_ PCR-assays is below 100 percent (*)
- the positive predictive value of a test is very strongly influenced by the prevalence of disease

(*) Performance may not be the same for all commercially available tests; there are few head-to head comparisons of apparatus/assays (reference 27 of the paper https://www.mja.com.au/journal/2015/202/6/gonorrhoea-notifications-and-nucleic-acid-amplification-testing-very-low is particularly helpful).

[Reference 27. Van Der Pol B, Liesenfeld O, Williams JA, et al: Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of _Chlamydia trachomatis_ and _Neisseria gonorrhoeae_. J Clin Microbiol 2012; 50(7): 2244-9.]

--
Prof Andre Burnens MD
Senior Microbiologist
Bioanalytica
Lucerne, Switzerland
<aburnens@bluewin.ch>

[ProMED-mail thanks Dr Andre Burnens for his comments on the effect that a test's specificity of less than 100 percent has on the positive predictive value in low prevalence populations. A review article on this subject can be found at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871692/
(Whiley DM, Tapsall JW, Sloots TP: Nucleic Acid Amplification Testing for _Neisseria gonorrhoeae_. An Ongoing Challenge. J Mol Diagn. 2006; 8(1): 3-15). - Mod.ML

A HealthMap/ProMED-mail map can be accessed at: https://promedmail.org/promed-post?place=3284108,288.]
See Also
Gonococcal disease - Australia (02): (VI) screening, NAAT, comment 20150408.3284083
Gonococcal disease - Australia: (VI) screening, NAAT 20150401.3270179
2014
----
Syphilis & gonococcal disease - Australia: MSM, decreasing condom use 20140920.2789253
Gonococcal disease - Australia: ceftriaxone resistance 20140826.2723627
Gonococcal disease - Australia: (NS) increased incidence 20140619.2552639
.................................................ml/mj/mpp
</body>
